1. Home
  2. CMND vs CWD Comparison

CMND vs CWD Comparison

Compare CMND & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • CWD
  • Stock Information
  • Founded
  • CMND 2017
  • CWD 2009
  • Country
  • CMND Canada
  • CWD United States
  • Employees
  • CMND N/A
  • CWD N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • CWD Real Estate
  • Sector
  • CMND Health Care
  • CWD Finance
  • Exchange
  • CMND Nasdaq
  • CWD Nasdaq
  • Market Cap
  • CMND 4.8M
  • CWD 4.5M
  • IPO Year
  • CMND N/A
  • CWD 2023
  • Fundamental
  • Price
  • CMND $0.99
  • CWD $3.39
  • Analyst Decision
  • CMND
  • CWD
  • Analyst Count
  • CMND 0
  • CWD 0
  • Target Price
  • CMND N/A
  • CWD N/A
  • AVG Volume (30 Days)
  • CMND 2.2M
  • CWD 23.9K
  • Earning Date
  • CMND 06-12-2025
  • CWD 08-11-2025
  • Dividend Yield
  • CMND N/A
  • CWD N/A
  • EPS Growth
  • CMND N/A
  • CWD N/A
  • EPS
  • CMND N/A
  • CWD N/A
  • Revenue
  • CMND N/A
  • CWD $35,429,000.00
  • Revenue This Year
  • CMND N/A
  • CWD N/A
  • Revenue Next Year
  • CMND N/A
  • CWD $31.12
  • P/E Ratio
  • CMND N/A
  • CWD N/A
  • Revenue Growth
  • CMND N/A
  • CWD N/A
  • 52 Week Low
  • CMND $0.80
  • CWD $3.00
  • 52 Week High
  • CMND $2.30
  • CWD $16.96
  • Technical
  • Relative Strength Index (RSI)
  • CMND 55.23
  • CWD 48.36
  • Support Level
  • CMND $0.94
  • CWD $3.13
  • Resistance Level
  • CMND $1.05
  • CWD $3.75
  • Average True Range (ATR)
  • CMND 0.08
  • CWD 0.30
  • MACD
  • CMND 0.02
  • CWD 0.05
  • Stochastic Oscillator
  • CMND 34.38
  • CWD 53.25

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

Share on Social Networks: